87 related articles for article (PubMed ID: 8224192)
1. Acidic pH increases the oxidation of LDL by macrophages.
Morgan J; Leake DS
FEBS Lett; 1993 Nov; 333(3):275-9. PubMed ID: 8224192
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of low density lipoprotein by iron or copper at acidic pH.
Morgan J; Leake DS
J Lipid Res; 1995 Dec; 36(12):2504-12. PubMed ID: 8847477
[TBL] [Abstract][Full Text] [Related]
3. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
Leake DS
Atherosclerosis; 1997 Mar; 129(2):149-57. PubMed ID: 9105556
[TBL] [Abstract][Full Text] [Related]
4. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein.
Lamb DJ; Leake DS
FEBS Lett; 1994 Sep; 352(1):15-8. PubMed ID: 7925932
[TBL] [Abstract][Full Text] [Related]
5. Iron-ascorbate-phospholipid mediated modification of low density lipoprotein.
Greenspan P; Yu H; Gutman RL; Mao F; Ryu BH; Lou P
Biochim Biophys Acta; 1996 Jun; 1301(3):242-8. PubMed ID: 8664335
[TBL] [Abstract][Full Text] [Related]
6. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein.
Lamb DJ; Leake DS
FEBS Lett; 1994 Jan; 338(2):122-6. PubMed ID: 8307168
[TBL] [Abstract][Full Text] [Related]
7. Hydroxypyridinones and desferrioxamine inhibit macrophage-mediated LDL oxidation by iron but not by copper.
Lamb DJ; Hider RC; Leake DS
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):234S. PubMed ID: 8224391
[No Abstract] [Full Text] [Related]
8. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway.
Katsura M; Forster LA; Ferns GA; Anggård EE
Biochim Biophys Acta; 1994 Jul; 1213(2):231-7. PubMed ID: 8025135
[TBL] [Abstract][Full Text] [Related]
9. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages.
Lamb DJ; Mitchinson MJ; Leake DS
FEBS Lett; 1995 Oct; 374(1):12-6. PubMed ID: 7589497
[TBL] [Abstract][Full Text] [Related]
10. Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution.
Kritharides L; Jessup W; Dean RT
Arch Biochem Biophys; 1995 Oct; 323(1):127-36. PubMed ID: 7487058
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis.
Hogg N; Kalyanaraman B; Joseph J; Struck A; Parthasarathy S
FEBS Lett; 1993 Nov; 334(2):170-4. PubMed ID: 8224243
[TBL] [Abstract][Full Text] [Related]
12. The effects of ascorbate and dehydroascorbate on the oxidation of low-density lipoprotein.
Stait SE; Leake DS
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):373-81. PubMed ID: 8973543
[TBL] [Abstract][Full Text] [Related]
13. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein.
Neugarten J; Ghossein C; Silbiger S
J Lab Clin Med; 1995 Oct; 126(4):385-91. PubMed ID: 7561448
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid can either increase or decrease low density lipoprotein modification.
Stait SE; Leake DS
FEBS Lett; 1994 Mar; 341(2-3):263-7. PubMed ID: 8137950
[TBL] [Abstract][Full Text] [Related]
15. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL.
Wang X; Greilberger J; Ledinski G; Kager G; Paigen B; Jürgens G
Atherosclerosis; 2004 Feb; 172(2):239-46. PubMed ID: 15019533
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of heparin-treated low density lipoprotein by peroxidases.
Upritchard JE; Sutherland WH
Atherosclerosis; 1999 Oct; 146(2):211-9. PubMed ID: 10532677
[TBL] [Abstract][Full Text] [Related]
17. [The effect of natural polyphenol compounds on the oxidative modification of low-density lipoproteins].
Dushkin MI; Zykov AA; Pivovarova EN
Biull Eksp Biol Med; 1993 Oct; 116(10):393-5. PubMed ID: 8117961
[TBL] [Abstract][Full Text] [Related]
18. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
Meyer DF; Mayans MO; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen.
Chang GJ; Woo P; Honda HM; Ignarro LJ; Young L; Berliner JA; Demer LL
Arterioscler Thromb; 1994 Nov; 14(11):1808-14. PubMed ID: 7947607
[TBL] [Abstract][Full Text] [Related]
20. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
Yuan XM; Anders WL; Olsson AG; Brunk UT
Atherosclerosis; 1996 Jul; 124(1):61-73. PubMed ID: 8800494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
